I'd be curious to hear your thoughts on this—latest CAD Revascularization guidelines from ACC, AHA, SCAI downgrade CABG due to ISCHEMIA trial, but surgeon groups AATS, STS object.
How does your organization reach best practice consensus? Do you rely on guidelines from ACC/AHA/SCAI? And does this disagreement throw a wrench in the mix?